CHEMICAL AND PHYSICAL PROPERTIES
| Color/Form | Amorphous, white to off-white powder |
|---|---|
| Solubility | Soluble in water |
| Other Experimental Properties | 16 amino acid peptide |
COMPUTED DESCRIPTORS
| Molecular Weight | 1681.9 g/mol |
|---|---|
| XLogP3 | -8.2 |
| Hydrogen Bond Donor Count | 23 |
| Hydrogen Bond Acceptor Count | 31 |
| Rotatable Bond Count | 28 |
| Exact Mass | 1680.6252002 g/mol |
| Monoisotopic Mass | 1680.6252002 g/mol |
| Topological Polar Surface Area | 819 Ų |
| Heavy Atom Count | 113 |
| Formal Charge | 0 |
| Complexity | 3490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 16 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It should not be used in children less than six years of age, and should be avoided in patients six years to 18 years of age